-- Aastrom's Proprietary Technology Used to Produce Therapeutic Quantities of T-Cells --

Aastrom Biosciences Corrects Warrant Exercise Price Related to April 5, 2004 Sale of Common Stock Ann Arbor, Michigan, April 6, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that the exercise price of the warrants issued to a group of institutional investors was $1.65 per share

Aastrom Biosciences Announces $9.1 Million Private Placement of Common Stock Ann Arbor, Michigan, April 5, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it has placed 8 million shares of common stock with institutional investors at approximately $1.14 per share, for an

-- Aastrom's Proprietary TRCs to be Utilized in Second European Clinical Study to Treat Major Bone Fractures --

-- New Form Simplifies Enrollment for Shareholders with Shares in "Street Name" --

-- Patent Covers Bone Marrow, Blood and Cord Blood-Sourced Products --

Aastrom Biosciences' CEO to Present at Roth Capital Partners 16th Annual Growth Stock Conference Ann Arbor, Michigan, February 12, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that R. Douglas Armstrong, Ph.D., Chairman, President and Chief Executive Officer, has been invited

Linda Manoogian Fingerle Appointed to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, February 5, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that Linda Manoogian Fingerle was appointed to the Company's Board of Directors. Ms.

Aastrom Biosciences, Inc. Reports Second Quarter Fiscal Year 2004 Financial Results Ann Arbor, Michigan, February 4, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM), today reported financial results for the second quarter of fiscal year 2004 ended December 31, 2003.

astrom Biosciences to Hold Investor Conference Call Tomorrow Ann Arbor, Michigan, February 3, 2004 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today that it will hold an investor conference call tomorrow, Wednesday, February 4, 2004 at 11:00 a.m. EST.